Skip to main content
. 2013 Dec 24;4(2):197–204. doi: 10.5681/apb.2014.029

Table 4. Post compression evaluation of Rosuvastatin liquisolid tablets .

Batch Thickness (mm) Hardness (kg/cm2) Weight variation (mg) Friability Disintegration time (sec) Drug content (%) FM
F1 3.02±0.01 4.20±0.24 151.45±0.95 0.095 175.00±0.63 96.66±1.31 0.771
F2 3.53±0.01 4.08±0.25 256.51±0.95 0.126 210.00±0.89 92.83±1.32 0.771
F3 3.45±0.01 4.00±0.15 363.64±0.85 0.274 143.33±0.81 96.66±1.31 0.771
F4 2.06±0.01 3.33±0.51 110.96±1.10 0.089 253.5±1.37 92.85±1.28 0.578
F5 3.42±0.01 4.00±0.44 363.62±0.91 0.072 307.0±0.89 96.66±1.31 0.578
F6 3.63±0.00 3.66±0.51 272.27±0.95 0.099 226.83±1.16 90.58±1.36 0.578
F7 3.00±0.02 3.5±0.44 187.25±1.19 0.094 354.66±0.81 90.58±1.36 0.462
F8 2.84±0.00 3.58±0.58 151.8±0.92 0.199 182.83±0.75 92.11±1.28 0.462
F9 2.65±0.01 4.00±0.31 216.20±0.44 0.168 254.66±1.03 95.13±1.32 0.462
*All readings are average ± SD (n=3)